Do you suffer from fibromyalgia, chronic fatigue, autoimmune disease, inflammation, or chronic pain?
Low Dose Naltrexone (LDN) is gaining attention as a potential therapy that may help regulate the immune system and reduce inflammation—yet most patients and providers have never heard of it.
Read MoreJoin this free webinar to learn how LDN works, who may benefit, and how personalized compounding makes it possible.
Compounding pharmacist Brad White was recently featured on the Made to Be Whole podcast, diving deep into the power of Low Dose Naltrexone (LDN) and the essential role of compounding pharmacies in personalized healthcare.
Read MoreAutoimmune diseases are a complex group of conditions in which the immune system mistakenly attacks healthy cells and tissues. While treatment options exist to manage symptoms, there is no known cure for autoimmune diseases. However, recent research has shed light on the potential benefits of Low Dose Naltrexone (LDN) in managing these conditions. In this blog post, we'll explore some of the latest research findings on the use of LDN in autoimmune diseases.
Read MoreLow Dose Naltrexone (LDN) is increasingly used by clinicians for management of challenging medical conditions such as chronic pain or autoimmune disorders.
Read MoreEpilepsy is a broad term used to describe people who suffer multiple seizures in their life time. Seizures are defined as sudden, uncontrolled electrical brain activity. Depending on how the brain looks at these electrical currents a person may change behavior, display abnormal movement or even lose consciousness. Low Dose Naltrexone has shown promise as an alternative treatment option for seizure disorders.
Read MoreNaltrexone is classified as an opioid antagonist. Naltrexone blocks opiate drugs from binding to the opioid receptors, which can result in increased endorphin and enkephalin release. This causes a biological response that results in reduced signaling and release of inflammatory substances, nerve cell inflammation and autoimmune mediators. LDN has been studied across a wide variety of autoimmune conditions and cancer diagnosis.
Read MoreCOVID-19 sparks an inflammatory immune response that is essential to control and eliminate the infection, however, certain immune responses can cause a decrease of gas exchange in the lungs.
Read MoreThe LDN Research Trust released a documentary earlier this month that provides education for patients that are suffering from chronic pain and are dependent on opioid prescription medication.
Read MoreAutoimmune conditions like Alzheimer’s Disease may be linked to chronic inflammation of nervous system. Does the future of new treatments focus on controlling inflammation and how can low dose naltrexone play a role?
Read MorePatients living with chronic pain are turning to low dose naltrexone as a solution to opioid medications to get their quality of life back to normal. NPR publishes a very well written article about LDN and cites both patient experience and references to clinical research for validation.
Read More
